SCHEMBL9937653

SCHEMBL9937653

Cc1ccncc1C(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
SIRT3 Q9NTG7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
F12 P00748 4/20 0.33
HIPK2 Q9H2X6 2/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
ROCK2 O75116 1/20 0.32
MAPT P10636 4/20 0.32
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937599 0.85 KMT2A (0.53) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL9937518 0.80 KMT2A (0.38) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL23199773 0.78 HSD17B10 (0.44) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL668901 0.78 CA12 (0.41) KMT2AMEN1TDP1CYP3A4MAPT
SCHEMBL996026 0.78 CA12 (0.41) KMT2AMEN1TDP1CYP3A4MAPT
SCHEMBL9937557 0.77 MAPT (0.41) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL669403 0.76 KMT2A (0.55) KMT2AMEN1TDP1MAPTKDM4E
SCHEMBL9936930 0.75 ACHE (0.41) KMT2AMEN1NPC1TDP1CYP3A4
SCHEMBL9938274 0.75 ELANE (0.38) TDP1CYP1A2ROCK2ALDH1A1LMNA
SCHEMBL9938547 0.75 KDM4E (0.40) KMT2ANPC1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed